Protocols
1 protocol(s) meet the specified criteria
Drug: Olaparib
Protocol No.TitleStatus
C16-168A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair DefectsOpen